Iterum Therapeutics plc (ITRMF) Revenue (2017 - 2025)

Iterum Therapeutics has reported Revenue for 4 years, with the latest figure at $390000.0 in Q3 2025.

• On a quarterly basis, Revenue changed N/A year-over-year to $390000.0 in Q3 2025; TTM through Sep 2025 was $390000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $37000.0, down 95.74% from the prior year.
• Revenue was $390000.0 for Q3 2025 at Iterum Therapeutics, up from $37000.0 in the prior quarter.
• The five-year high for Revenue was $390000.0 in Q3 2025, with the low at $390000.0 in Q3 2025.